The function of long non-coding RNA in non-alcoholic fatty liver disease

被引:3
作者
Cao, Lianrui [1 ]
Qu, Na [1 ]
Wang, Xin [1 ]
Chen, Lijiang [1 ]
Liu, Mingxia [1 ]
机构
[1] Liaoning Univ, Sch Pharmaceut Sci, 66 Chongshan Mid Rd, Shenyang 110036, Peoples R China
基金
中国国家自然科学基金;
关键词
Long non -coding RNA; Non-alcoholic fatty; Metabolism; Mechanism; liver disease; HEPATIC GLUCONEOGENESIS; INSULIN; MICRORNA-214; METABOLISM; CAVEOLIN-1; DIAGNOSIS; GLUCOSE;
D O I
10.1016/j.clinre.2023.102095
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Non-alcoholic fatty liver disease is a disease that is currently prevalent in the world, increasingly becoming the mainstay of liver diseases. And its prevalence is rapidly increasing, but its pathogenesis is not entirely understood. Long non-coding RNAs have increasingly gained attention as science has progressed in recent years. Studies have shown that long non-coding RNAs are involved in a variety of biological processes in vivo, such as proliferation, differentia-tion, and apoptosis, and can affect disease by regulating gene expression. This review explores the biological processes involving long non-coding RNAs, including lipid metabolism, glucose metabolism, liver fibrosis, and apoptosis. In addition, we summarize how the different long non -coding RNAs involved in each process function. Finally, the shortcomings of long non-coding RNAs as potential therapeutic targets are briefly described. In conclusion, this article provides a clear visualization of the link that exists between long non-coding RNAs and non-alcoholic fatty liver disease.(c) 2023 Elsevier Masson SAS. All rights reserved.
引用
收藏
页数:8
相关论文
共 54 条
[1]   Long non-coding RNAs in metabolic disorders: pathogenetic relevance and potential biomarkers and therapeutic targets [J].
Alipoor, B. ;
Nikouei, S. ;
Rezaeinejad, F. ;
Malakooti-Dehkordi, S-N. ;
Sabati, Z. ;
Ghasemi, H. .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2021, 44 (10) :2015-2041
[2]  
Altinbas A, 2015, MINERVA GASTROENTERO, V61, P159
[3]   TGF-β signaling is activated in patients with chronic HBV infection and repressed by SMAD7 overexpression after successful antiviral treatment [J].
Argentou, Nikoletta ;
Germanidis, Georgios ;
Hytiroglou, Prodromos ;
Apostolou, Eirini ;
Vassiliadis, Themistoklis ;
Patsiaoura, Kalliopi ;
Sideras, Paschalis ;
Germenis, Anastasios E. ;
Speletas, Matthaios .
INFLAMMATION RESEARCH, 2016, 65 (05) :355-365
[4]   A Liver-Specific Long Noncoding RNA With a Role in Cell Viability Is Elevated in Human Nonalcoholic Steatohepatitis [J].
Atanasovska, Biljana ;
Rensen, Sander S. ;
van der Sijde, Marijke R. ;
Marsman, Glenn ;
Kumar, Vinod ;
Jonkers, Iris ;
Withoff, Sebo ;
Shiri-Sverdlov, Ronit ;
Greve, Jan Willem M. ;
Faber, Klaas Nico ;
Moshage, Han ;
Wijmenga, Cisca ;
van de Sluis, Bart ;
Hofker, Marten H. ;
Fu, Jingyuan .
HEPATOLOGY, 2017, 66 (03) :794-808
[5]   The Roles of mTOR Complexes in Lipid Metabolism [J].
Caron, Alexandre ;
Richard, Denis ;
Laplante, Mathieu .
ANNUAL REVIEW OF NUTRITION, VOL 35, 2015, 35 :321-348
[6]   Homeostasis of Glucose and Lipid in Non-Alcoholic Fatty Liver Disease [J].
Chao, Hsu-Wen ;
Chao, Shi-Wei ;
Lin, Heng ;
Ku, Hui-Chen ;
Cheng, Ching-Feng .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (02)
[7]   LncRNA NEAT1 promotes hepatic lipid accumulation via regulating miR-146a-5p/ROCK1 in nonalcoholic fatty liver disease [J].
Chen, Xi ;
Tan, Xin-Rui ;
Li, Shi-Jun ;
Zhang, Xing-Xing .
LIFE SCIENCES, 2019, 235
[8]   Long noncoding RNA FLRL2 alleviated nonalcoholic fatty liver disease through Arntl-Sirt1 pathway [J].
Chen, Yi ;
Chen, Xueyang ;
Gao, Jianguo ;
Xu, Chengfu ;
Xu, Ping ;
Li, Youming ;
Zhu, Yong ;
Yu, Chaohui .
FASEB JOURNAL, 2019, 33 (10) :11411-11419
[9]   Long Non-Coding RNA Profiling in a Non-Alcoholic Fatty Liver Disease Rodent Model: New Insight into Pathogenesis [J].
Chen, Yi ;
Huang, Haixiu ;
Xu, Chengfu ;
Yu, Chaohui ;
Li, Youming .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (01)
[10]   Long noncoding RNA lncARSR promotes nonalcoholic fatty liver disease and hepatocellular carcinoma by promoting YAP1 and activating the IRS2/AKT pathway [J].
Chi, Yuan ;
Gong, Zheng ;
Xin, He ;
Wang, Ziwen ;
Liu, Zhaoyu .
JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18 (01)